GlassScriptPhysician profile
Tanner Harding
NPI 1194427336
$2,287.85
in general payments reported to CMS, 2019-2025
10 companies · $1,993 in 2025
The $1,993 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $295 · 2025: $1,993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,114 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,113.62 |
| Education | $174.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $504.61 | 2024-2025 | |
| Abbvie INC. | $487.38 | 2025 | Skyrizi, Rinvoq |
| Incyte Corporation | $457.90 | 2024-2025 | Opzelura, Opzelura |
| Janssen Scientific Affairs, LLC | $272.24 | 2025 | Tremfya |
| Janssen Biotech, INC. | $103.46 | 2025 | Tremfya |
| Organon LLC | $101.75 | 2025 | Vtama |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Krystal Biotech INC | $99.07 | 2024 | Vyjuvek |
| Biofrontera INC. | $83.77 | 2025 | Ameluz, Bf-Rhodoled |
| Stimlabs LLC | $77.68 | 2025 | Allacor P |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanner Harding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.